Top Stock Movers Today — August 10, 2026: Why JWEL, BWMN, VREX, HZO & ABCL Surged
Five stocks led the market today: JWEL surged 155%, BWMN jumped 56% on a merger, HZO soared 46% on a $1.5B buyout, and ABCL rocketed 35% on a hot-flash drug trial win.
JWEL — Jowell Global Ltd. (+155.5%)
Jowell Global closed up 155.5% at $3.96 on a staggering 969.2 million shares — roughly 20× its 20-day average volume of 48.5 million. That is an extraordinary surge in activity for a stock with a market cap of just $3.5 million, which by definition makes it a micro-float name (a low-float stock is one where very few shares are freely tradeable, meaning even modest buying pressure can send the price sharply higher). The day's gap — where the stock opened dramatically above the prior close — clocked in at +156.1%, and JWEL closed at a 52-week high.
Why it moved: According to reporting from Advfn on August 10, Jowell Global shares soared in pre-market trading without a clear catalyst. No confirmed merger, earnings release, or material announcement was on file to explain the move. The two Yahoo Finance headlines in the data for August 6 are about Jamieson Wellness Inc. (ticker JWN.TO), a separate company — they are not relevant to Jowell Global and should not be conflated. This move appears to be driven by momentum and speculative trading rather than fundamental news.
From a technical standpoint, StockSetups flagged a technical rank of 96 and a conviction score of 60/100 (grade B). RSI came in at 64 before the gap exploded the price, and ADX of 10 signaled a weak underlying trend prior to the move — meaning the tape was quiet before this eruption, which is a common setup for explosive low-float runs. The moving-average stack was mixed heading in, suggesting no established trend was in place.
Stocks like JWEL — tiny market cap, no clear catalyst, volume 20× the norm — are among the most dangerous chases in the market. They can reverse just as violently. JWEL was also flagged in this morning's premarket recap, where the same absence of catalyst was noted.
BWMN — Bowman Consulting Group Ltd. (+55.8%)
Bowman Consulting Group surged 55.8% to $42.43, with 9.23 million shares changing hands against a 20-day average of just 611,700 — roughly 15× normal volume. The stock gapped up +55.3% at the open and held its gains through the close, finishing just 4.5% below its 52-week high.
Why it moved: Yahoo Finance reported on August 10 that Bowman Consulting shares rose on higher Q2 adjusted earnings and a merger deal with Bernhard Capital Partners. That double catalyst — a beat on quarterly results combined with a definitive acquisition agreement — is a classic driver of large single-day gaps. TradingView also noted that a 12-month price target was raised to $49.33. Smart-money context: a 13.7% largest-disclosed stake on file indicates a significant institutional or insider position in the company, which is worth noting in a buyout context.
Technically, StockSetups showed an RSI of 86 (deep into overbought territory — a level where the price has risen very fast relative to recent history) and an ADX of 25, suggesting trend momentum strengthened on the day. The conviction score was 47/100 (grade C) heading into the session, and the trend-template score was 4/100 — meaning the chart had not yet established a clean Minervini-style uptrend before news rewrote the picture. A recent Schedule 13G/A (a filing that signals a change in a large passive institutional stake) was filed August 6, and a 144 filing (a notice of intent by an insider to sell shares) appeared August 7 — neither is abnormal for a company about to be acquired.
Merger-driven gaps can be sticky if the deal is at a fixed price, but deal risk (the chance a transaction falls through) is always present. Do not assume the gap holds.
VREX — Varex Imaging Corp. (+48.7%)
Varex Imaging closed up 48.7% at $18.45 on volume of 7.57 million shares, versus its 20-day average of 703,722 — more than 10× normal. The stock gapped +48.2% and closed right at a 52-week high, earning an RS rating of 94 (meaning it outperformed 94% of all stocks in the market over the recent period).
Why it moved: There are no news headlines on file for VREX for August 10, and the only recent SEC filing is a passive Schedule 13G from July 31 (a routine disclosure when an institutional investor crosses a 5% ownership threshold — the largest disclosed stake here is 5.1%). The catalyst for this move is unclear from available data. Given the magnitude of the gap, volume surge, and the fact that Varex is a technology-sector company, the most likely explanation is either an undisclosed pre-market catalyst (such as an earnings report or M&A rumor) or an intense momentum/technical squeeze. The smart-money score of 31/100 is below average, so institutional conviction heading in was modest.
StockSetups gave VREX a technical rank of 94 and a conviction score of 59/100 (grade C) with a trend-template score of 4. RSI hit 92 by the close — an extremely elevated reading that signals the stock moved very far, very fast. ADX of 25 shows the trend strengthened sharply intraday. Because no confirmed catalyst is on file, traders considering this name should treat the move as momentum-driven until a clear fundamental reason emerges. High relative volume (RVOL) without a known catalyst is often a signal worth investigating further — our RVOL explainer covers how to read this signal.
HZO — MarineMax Inc. (+46.0%)
MarineMax was one of the day's most clear-cut big-news movers, closing up 46.0% at $52.10 on 12.66 million shares — roughly 13.7× its 20-day average of 926,091. The stock gapped +45.5% and closed at a 52-week high. With a market cap of $788.1 million, this is a mid-cap name with real liquidity behind the move.
Why it moved: Yahoo Finance confirmed on August 10 that MarineMax entered into a definitive agreement to be acquired by Safe Harbor — a Blackstone Infrastructure portfolio company — in a $1.5 billion all-cash transaction. Advfn's headline put it simply: "MarineMax shares surge on report of $1.5 billion Safe Harbor takeover." All-cash buyout announcements almost always produce immediate, large gaps as the stock price moves toward the deal price. The earlier July 23 10-Q and 8-K earnings filing suggest the company had been reporting normally before the deal was announced.
StockSetups gave HZO its highest marks of all five today's movers: a conviction score of 91/100 (grade A+) and a trend-template score of 8/100 — reflecting a healthy bullish MA stack heading into the session. The RSI closed at 83 and the technical rank was 97. The MA stack was already bullish before news hit, suggesting institutions may have been accumulating shares ahead of the announcement. RS rating of 92 rounds out a technically sound picture that the catalyst then supercharged.
In buyout situations, the stock will often trade near (but not exactly at) the deal price, with the small remaining gap reflecting deal-completion risk and time value. Chasing above the deal price is a well-known trap for retail traders.
ABCL — AbCellera Biologics Inc. (+34.7%)
AbCellera Biologics closed up 34.7% at $9.34 on 34.1 million shares — more than 5× its 20-day average of 6.5 million. The stock gapped +26.6% at the open and continued higher through the session to close at a 52-week high. With a market cap of $2.1 billion, ABCL is the largest company in today's top-five group.
Why it moved: Multiple sources converged on the same catalyst. Bloomberg reported the stock rose as much as 41% after a hot-flash drug trial result; Yahoo Finance described AbCellera "rocketing" on news that a hot-flash (menopause) treatment hit all primary and secondary goals in its clinical trial. TechStock² noted the jump tied directly to the trial hitting "all main and secondary goals." Clinical trial success — especially when a drug meets both its primary and secondary endpoints — is one of the most powerful single-day catalysts in biotech, as it dramatically changes the probability that a drug will reach market approval and generate revenue. GuruFocus flagged a valuation caution, noting ABCL looked 64.1% overvalued on its GF Value metric even amid the positive news — a reminder that good science and an attractive stock price are different things. MarketBeat also noted unusually high options volume, consistent with the broad market attention the trial news attracted.
StockSetups rated ABCL with a perfect conviction score of 100/100 (grade A+) and a trend-template score of 8 — the joint-highest in today's group alongside HZO. The RSI of 77 and bullish MA stack show the stock was already in a constructive technical position before news hit. RS rating of 94 and technical rank of 98 make this one of the strongest-rated names in the broader scan. An insider buy of 20,000 shares (~$95K) by John S. Montalbano on May 14 is a positive signal on record, though it predates today's catalyst by several months. Reddit buzz on r/all-stocks (rank #142, up from 1 mention 24 hours ago to 3 mentions) is beginning to build but remains modest for now.
The bottom line
Today's five biggest gainers illustrate how different catalysts can produce similar-looking price explosions: a confirmed $1.5 billion all-cash buyout (HZO), a merger plus earnings beat (BWMN), a clinical trial hitting all endpoints (ABCL), a gap with no confirmed catalyst (VREX), and a momentum-driven micro-cap spike with no clear news (JWEL).
The risk picture is equally varied — but universally real. Stocks that move 35%–155% in a single session are among the most dangerous to chase. Merger gaps trade at deal risk; clinical-trial pops can reverse if follow-on data disappoints or regulatory risk resurfaces; momentum moves without catalysts can unwind just as fast as they form. Extended RSI readings (VREX at 92, BWMN at 86) signal that near-term mean-reversion pressure exists. Big one-day gainers frequently give back a significant portion of their move in subsequent sessions. None of this is financial advice or a recommendation to buy or sell any security — it is education. Do your own research and manage your risk carefully.
StockSetups scans the full ~12,300-stock US universe after every close, detecting chart patterns, scoring conviction and short-squeeze potential, and sorting setups across four actionable lanes — so you can find tomorrow's movers before the crowd does. For this morning's pre-market version of today's story, see the August 10 premarket recap. You can also review the August 7 after-close recap for recent market context.
Frequently asked questions
Why is JWEL stock up today?
Jowell Global surged 155.5% on August 10, 2026, on volume roughly 20 times its normal level, but no confirmed catalyst was identified. Reporting from Advfn noted the shares soared without a clear reason, making this a momentum- and technically-driven move in an extremely low-market-cap stock.
Why is HZO (MarineMax) stock up today?
MarineMax jumped 46% after the company announced a definitive agreement to be acquired by Safe Harbor — a Blackstone Infrastructure portfolio company — in a $1.5 billion all-cash transaction. All-cash buyout announcements typically push a stock sharply toward the deal price.
Why is ABCL (AbCellera) stock up today?
AbCellera closed up nearly 35% after its hot-flash (menopause) treatment hit all primary and secondary goals in a clinical trial. Trial success on all endpoints is one of the most powerful catalysts in biotech, dramatically improving the odds a drug reaches market approval.
Why is BWMN (Bowman Consulting) stock up today?
Bowman Consulting surged 55.8% on a combination of higher-than-expected Q2 adjusted earnings and a definitive merger agreement with Bernhard Capital Partners. The double catalyst — a quarterly beat plus an acquisition deal — drove the stock to gap open more than 55% above Friday's close.
What is a low-float stock and why does it move so violently?
A low-float stock has very few shares freely available to trade. When buy orders surge — whether from news, momentum traders, or short sellers forced to cover — there are not enough shares to absorb demand, so the price can spike sharply. The flip side is equally violent: once buying dries up, prices can collapse just as fast. JWEL is a textbook example of a micro-float, micro-cap stock that moved explosively without a confirmed catalyst.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →